People who talk with their doctors are more likely to get vaccinated during a pandemic, according to a study of evidence collected during the ''swine flu,'' the last pandemic to hit the U.S. before COVID-19. Researchers surveyed patients about the vaccine for the H1N1 virus (swine flu). They found that doctor-patient communication helped build trust in physicians, leading to more positive attitudes toward the vaccine--and it correlated to people actually getting vaccinated.
Within the next decade, the novel coronavirus responsible for COVID-19 could become little more than a nuisance, causing no more than common cold-like coughs and sniffles. That possible future is predicted by mathematical models that incorporate lessons learned from the current pandemic on how our body's immunity changes over time.
'Pretty' parrots are more likely to be snatched up for Indonesia's illegal wildlife trade, a new study reveals. The findings not only expose the key drivers behind the country's illegal trade in these birds, but offer lessons for the potential emergence and spread of infectious diseases that jump from animals to humans.
Australian researchers have identified the immune response associated with protection from COVID-19 -- a discovery that may help cut the time it takes to develop new vaccines.
A study of the 2020 influenza figures from Canada, the United States, Australia and Brazil shows that there is a clear relationship between COVID-mitigation measures such as hand-washing, masking and social distancing and the spread of the annual flu, researchers report. They write that these preventive measures all but eliminated the flu in countries where it can kill tens of thousands of people a year, even as cases of COVID-19 soared.
Researchers have identified predictors of both severe disease and recovery in hospitalized influenza patients, finding that the immune system works in concert to fight influenza.
A comprehensive review into what we know about COVID-19 and the way it functions suggests the virus has a unique infectious profile, which explains why it can be so hard to treat and why some people experience so-called 'long-COVID'.
An influenza vaccine that is made of nanoparticles and administered through the nose enhances the body's immune response to influenza virus infection and offers broad protection against different viral strains, according to new research.
A new treatment is among the first known to reduce the severity of acute respiratory distress syndrome caused by the flu in animals, according to a new study.
Researchers showed that COVID-19 survivors -- including those not sick enough to be hospitalized -- have an increased risk of death in the six months following diagnosis with the virus. They also have catalogued the numerous diseases associated with COVID-19, providing a big-picture overview of the long-term complications of COVID-19 and revealing the massive burden this disease is likely to place on the world's population in the coming years.
Researchers have created a platform that can develop effective and highly specific peptide nucleic acid therapies for use against any bacteria within just one week. The work could change the way we respond to pandemics and how we approach increasing cases of antibiotic resistance globally.
Scientists have identified a set of human genes that fight SARS-CoV-2 infection, the virus that causes COVID-19. Knowing which genes help control viral infection can greatly assist researchers' understanding of factors that affect disease severity and also suggest possible therapeutic options. The genes in question are related to interferons, the body's frontline virus fighters.
A new study finds that convalescent plasma from recovered COVID-19 patients can dramatically improve likelihood of survival among blood cancer patients hospitalized with the virus. The therapy involves transfusing plasma from people who have recovered from COVID-19 into patients who have leukemia, lymphoma or other blood cancers and are hospitalized with the viral infection.
In a new study, the researchers found that the common respiratory virus jump-starts the activity of interferon-stimulated genes, early-response molecules in the immune system which can halt replication of the SARS-CoV-2 virus within airway tissues infected with the cold.
Gene expression patterns associated with pandemic viral infections provide a map to help define patients' immune responses, measure disease severity, predict outcomes and test therapies -- for current and future pandemics.
A new study shows that during the last great pandemic -- 2009's H1N1 influenza pandemic -- people developed strong, effective immune responses to stable, conserved parts of the virus.
Neurological and psychiatric symptoms such as fatigue and depression are common among people with COVID-19 and may be just as likely in people with mild cases, according to a new review.